Literature DB >> 12860288

Spontaneous development of hepatocellular carcinomas in the FLS mice with hereditary fatty liver.

Masahiko Soga1, Yoshio Kishimoto, Yoshihiro Kawamura, Shuichiro Inagaki, Susumu Makino, Toshiji Saibara.   

Abstract

The fatty liver Shionogi (FLS) mouse is an inbred strain that develops spontaneous fatty liver (hepatic steatosis) chronically without obesity. Here, we reported that the mice develop spontaneous hepatocellular tumors with high incidences. The mice with age of over 1 year frequently developed whitish protuberant nodules in the livers, which were histologically diagnosed as hepatocellular adenoma and/or carcinoma (HCC). An incidence of HCC was 12/30 (40%) in males at 15-16 months of age, while in females that was 0/36 at 13-16 months and 4/42 (9.5%) at 20-24 months. Furthermore, histological examinations showed that after 2-4 months of age mononuclear cell infiltration and clusters of foamy cells appear in the fatty liver with elevated serum alanine aminotransferase, suggesting presence of inflammatory responses and liver injury. These observations show that the FLS mice develop hepatocellular tumors following steatohepatitis. The mouse might be a good animal model for investigating liver tumor and non-alcoholic steatohepatitis.

Entities:  

Mesh:

Year:  2003        PMID: 12860288     DOI: 10.1016/s0304-3835(03)00213-1

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  8 in total

1.  Hepatocellular carcinoma and nonalcoholic steatohepatitis developing during long-term administration of valproic acid.

Authors:  Katsuaki Sato; Yoshimichi Ueda; Keiichi Ueno; Kazuya Okamoto; Hideaki Iizuka; Shogo Katsuda
Journal:  Virchows Arch       Date:  2005-08-17       Impact factor: 4.064

2.  Risk factors for hepatocellular carcinoma (HCC) in the northeast of the United States: results of a case-control study.

Authors:  Yi Shen; Harvey Risch; Lingeng Lu; Xiaomei Ma; Melinda L Irwin; Joseph K Lim; Tamar Taddei; Karen Pawlish; Antoinette Stroup; Robert Brown; Zhanwei Wang; Wei Jia; Linda Wong; Susan T Mayne; Herbert Yu
Journal:  Cancer Causes Control       Date:  2020-02-14       Impact factor: 2.506

3.  Gene Expression Analysis of the Activating Factor 3/Nuclear Protein 1 Axis in a Non-alcoholic Steatohepatitis Mouse Model.

Authors:  Ran Nagahara; Tomomitsu Matono; Takaaki Sugihara; Yukako Matsuki; Masafumi Yamane; Toshiaki Okamoto; Kenichi Miyoshi; Takakazu Nagahara; Jun-Ichi Okano; Masahiko Koda; Hajime Isomoto
Journal:  Yonago Acta Med       Date:  2019-03-28       Impact factor: 1.641

Review 4.  How Useful Are Monogenic Rodent Models for the Study of Human Non-Alcoholic Fatty Liver Disease?

Authors:  Jake P Mann; Robert K Semple; Matthew J Armstrong
Journal:  Front Endocrinol (Lausanne)       Date:  2016-11-16       Impact factor: 5.555

Review 5.  Role of Neutrophils in the Pathogenesis of Nonalcoholic Steatohepatitis.

Authors:  Seonghwan Hwang; Hwayoung Yun; Sungwon Moon; Ye Eun Cho; Bin Gao
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-11       Impact factor: 5.555

6.  The FLS (fatty liver Shionogi) mouse reveals local expressions of lipocalin-2, CXCL1 and CXCL9 in the liver with non-alcoholic steatohepatitis.

Authors:  Toshihisa Semba; Motoi Nishimura; Satomi Nishimura; Osamu Ohara; Takayuki Ishige; Sayaka Ohno; Ken Nonaka; Kazuyuki Sogawa; Mamoru Satoh; Setsu Sawai; Kazuyuki Matsushita; Fumio Imazeki; Osamu Yokosuka; Fumio Nomura
Journal:  BMC Gastroenterol       Date:  2013-07-23       Impact factor: 3.067

Review 7.  Modeling progressive non-alcoholic fatty liver disease in the laboratory mouse.

Authors:  Jesse D Riordan; Joseph H Nadeau
Journal:  Mamm Genome       Date:  2014-05-07       Impact factor: 2.957

Review 8.  Mouse models of liver cancer: Progress and recommendations.

Authors:  Li He; De-An Tian; Pei-Yuan Li; Xing-Xing He
Journal:  Oncotarget       Date:  2015-09-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.